DiR Liposome@Pemafibrate (K-877) + surface peptide targeting peg2k-PECAM-1 (CD31)

DiR Liposome@Pemafibrate (K-877) + surface peptide targeting peg2k-PECAM-1 (CD31)/DiR Liposome loaded Pemafibrate(K-877) and surface peptide targeting peg2k-PECAM-1 (CD31),Drug loading 2mg is a customized scientific research formulation in the field of cardiovascular targeted drug delivery, which is a PECAM-1 (CD31) targeted pembrolizumab long circulating liposome labeled with DiR near-infrared fluorescence and loaded with 2mg. Currently, it is only in the laboratory research stage and has no clinical products on the market.

msds of DiR Liposome@Pemafibrate (K-877) + surface peptide targeting peg2k-PECAM-1 (CD31)